H-Thr-Thr-Thr-OH
56395-09-6
|
PKI (5-24)
99534-03-9
|
(2S)-2-[[(2S,3R)-2-[[(2S,3R)-2-amino-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]-N-[(2S)-1-[[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]butanediamide
123951-78-0
|
cAMP-Dependent Protein Kinase Inhibitor-α (5-22) amide (human, mouse, rabbit, rat)
100853-58-5
|
(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S,3R)-2-[[(2S,3R)-2-amino-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]-4-oxobutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]butanoic acid
123951-86-0
|
methyl (2S,3R)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S,3R)-2-[[(2S,3R)-2-amino-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]-4-oxobutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxybutanoate
123951-76-8
|
(Gln18)-Platelet Factor 4 (15-22) (human)
144207-60-3
|
h-thr(tbu)-pna
201807-08-1
|
H-Thr-Glu-OH
54532-73-9
|
4-(4-Benzylpiperazine-1-carbonyl)-2-cyclopropyl-6-(difluoromethyl)pyrimidine
2770592-71-5
|
rac-(1R,2S)-2-[3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-2-methoxypropanamido]cycloheptane-1-carboxylic acid
2228038-31-9
|
rac-(1R,2S)-2-[3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-2,2-difluoropropanamido]cycloheptane-1-carboxylic acid
2227760-22-5
|
2-Cyclopropyl-4-(difluoromethyl)-6-[4-(2-fluorophenyl)piperazine-1-carbonyl]pyrimidine
2770598-46-2
|
rac-(1R,2S)-2-(2-{[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)ethyl]sulfanyl}acetamido)cycloheptane-1-carboxylic acid
2227879-33-4
|
2-Cyclopropyl-4-(difluoromethyl)-6-[4-(4-fluorophenyl)piperazine-1-carbonyl]pyrimidine
2770590-57-1
|
[1-(But-1-en-1-yl)cyclopentyl]methanamine
2229649-82-3
|
2-Cyclopropyl-4-(difluoromethyl)-6-[4-(2-methoxyphenyl)piperazine-1-carbonyl]pyrimidine
2770615-68-2
|
2-cyclopropyl-6-(difluoromethyl)-N-phenylpyrimidine-4-carboxamide
2770586-42-8
|
2-[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3,3,3-trifluoropropanoyl]-2-azabicyclo[2.1.1]hexane-1-carboxylic acid
2171631-22-2
|
